Comparative Study of Olopatadine Hydrochloride 0.1% and Emedastine difumarate 0.05% Comparing their Clinical Efficacy and Adverse Effects in Allergic Conjunctivitis. mfm. 2024;26(5). Accessed November 17, 2025. https://medicalforummonthly.com/index.php/mfm/article/view/2774